Dendreon completes FDA submission for cancer drug
Dendreon completes FDA submission for potential prostate cancer treatment Provenge
- On 12:29 pm EST, Monday November 2, 2009
SEATTLE (AP) -- Dendreon Corp. said Monday it completed its Food and Drug Administration application for the potential cancer drug Provenge.
The drug is aimed at treating prostate cancer. It works as a vaccine to stimulate the body's immune system so it fights the cancer, but is given as a treatment rather than a preventive. The application is ahead of the company's prior timeline for 2010.
"With the BLA (application) submission complete, we have taken an important step towards reaching our goal of bringing a new therapy to men with advanced prostate cancer," said President and CEO Dr. Mitchell H. Gold, in a statement.
The company has previously said it hopes to gain FDA approval and launch the drug in 2010.
Shares of Dendreon rose 41 cents to $25.68 in afternoon trading. The stock has traded between $2.55 and $30.42 over the past 52 weeks.
Related Headlines
- Dendreon's Provenge gets FDA review date - AP
- Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst - Wall Street Transcript
- Dendreon Receives FDA Acknowledgement of Complete Response - PR Newswire
- DENDREON CORP Financials - EDGAR Online Financials
- DENDREON CORP Files SEC form 8-K, Results of Operations and Financial Condition - EDGAR Online
Related Blog Headlines
- May Day For Dendreon - at CNBC
- 2 Takeover Targets in the Pharma Market - at CNBC
- Dendreon's Provenge Looks Likely to Be Approved in Mid-2010 - at Seeking Alpha
- Biopharma's Bustin' Out All Over - at CNBC
- Dendreon Submits Prostate Cancer Treatment to FDA. Again. - at The Wall Street Journal Online
Sponsored Links
-
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT. -
Earn From 1.90% to 2.20% Apply Online
With GE Capital Corporation. Not An Offer Of Securities For Sale.
-
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today. -
Super Cheap Car Insurance Quotes
Get Discount Auto Insurance Quotes Online - Rates from $15 / Month.
Tech Ticker Recent Posts
- Housing Bottom? "Not Even Close," Barry Ritholtz Says - Aaron Task
- A Bad Economy Could Spell Good News on Wall Street for Years to Come - Peter Gorenstein
- The FDIC Is $8.2 Billion in the Hole - John Carney
Add Alert Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.